DK161026C - Analogifremgangsmaade til fremstilling af antigenderivater - Google Patents

Analogifremgangsmaade til fremstilling af antigenderivater

Info

Publication number
DK161026C
DK161026C DK079779A DK79779A DK161026C DK 161026 C DK161026 C DK 161026C DK 079779 A DK079779 A DK 079779A DK 79779 A DK79779 A DK 79779A DK 161026 C DK161026 C DK 161026C
Authority
DK
Denmark
Prior art keywords
preparation
analogy procedure
antigen derivatives
antigen
derivatives
Prior art date
Application number
DK079779A
Other languages
English (en)
Other versions
DK79779A (da
DK161026B (da
Inventor
Gerhard Baschang
Felix M Dietrich
Roland Gisler
Albert Hartmann
Jaroslav Stanek
Lajos Tarcsay
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27173419&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK161026(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK79779A publication Critical patent/DK79779A/da
Publication of DK161026B publication Critical patent/DK161026B/da
Application granted granted Critical
Publication of DK161026C publication Critical patent/DK161026C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6062—Muramyl peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK079779A 1978-02-24 1979-02-23 Analogifremgangsmaade til fremstilling af antigenderivater DK161026C (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CH203578 1978-02-24
CH203578 1978-02-24
CH377778 1978-04-07
CH377778 1978-04-07
CH539478 1978-05-18
CH539478 1978-05-18

Publications (3)

Publication Number Publication Date
DK79779A DK79779A (da) 1979-08-25
DK161026B DK161026B (da) 1991-05-21
DK161026C true DK161026C (da) 1991-10-28

Family

ID=27173419

Family Applications (1)

Application Number Title Priority Date Filing Date
DK079779A DK161026C (da) 1978-02-24 1979-02-23 Analogifremgangsmaade til fremstilling af antigenderivater

Country Status (20)

Country Link
EP (1) EP0003833B2 (da)
JP (1) JPS54141718A (da)
AR (1) AR223833A1 (da)
AT (1) AT364718B (da)
AU (1) AU527549B2 (da)
CA (1) CA1138436A (da)
DD (1) DD141616A5 (da)
DK (1) DK161026C (da)
ES (2) ES477977A1 (da)
FI (1) FI66878C (da)
GB (1) GB2015534A (da)
GR (1) GR77615B (da)
HU (1) HU182011B (da)
IL (1) IL56724A (da)
NO (2) NO151201C (da)
NZ (1) NZ189756A (da)
PL (1) PL123315B1 (da)
PT (1) PT69281A (da)
SU (1) SU1055312A3 (da)
ZA (1) ZA79893B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54130516A (en) * 1978-03-31 1979-10-09 Yuuichi Yamamura Acyllnnacetylmuramylpeptide derivativeeantigen combination
FR2428050A1 (fr) * 1978-06-05 1980-01-04 Anvar Oligomeres de composes du type muramyl-peptide et medicaments les contenant
FR2428051A1 (fr) * 1978-06-05 1980-01-04 Anvar Nouveaux composes du type muramyl-peptide et medicaments les contenant
US4335111A (en) 1978-12-22 1982-06-15 Agence National De Valorisation De La Recherche (Anvar) Compounds associating peptidyl of aminoacyl residues to lipophilic groups and pharmaceutical compositions containing said new compounds
FR2446292A1 (fr) * 1979-01-12 1980-08-08 Anvar Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant
FR2449697A1 (fr) 1979-02-20 1980-09-19 Anvar Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant
JPS5618996A (en) * 1979-06-21 1981-02-23 Dai Ichi Seiyaku Co Ltd Muramyldipeptide derivative
DK156252C (da) * 1979-07-31 1989-12-18 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af di-, tri- eller tetrapeptidderivater eller salte deraf
US4406889A (en) 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
EP0038153A3 (en) * 1980-04-15 1982-12-22 Beecham Group Plc Modified allergens
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
US4497729A (en) * 1980-12-01 1985-02-05 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
FR2522967B1 (fr) * 1982-03-15 1986-03-07 Anvar Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant
US4587046A (en) * 1982-05-18 1986-05-06 The Regents Of The University Of California Drug-carrier conjugates
FR2558165B1 (fr) * 1984-01-17 1986-07-04 Anvar Nouveaux conjugues d'oligo-muramylpeptides et compositions biologiques les contenant pour l'activation des macrophages
FR2569984B1 (fr) * 1984-09-12 1987-08-14 Anvar Molecule synthetique contenant une pluralite d'epitopes distincts, procede pour son obtention et application a la production de polyvaccins
AU2022239614A1 (en) 2021-03-19 2023-10-12 Icahn School Of Medicine At Mount Sinai Compounds for regulating trained immunity, and their methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH453269A4 (da) * 1968-03-29 1973-01-31
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
CH613709A5 (en) * 1975-12-10 1979-10-15 Ciba Geigy Ag Process for the preparation of glucosamine derivatives
GB1573126A (en) * 1976-03-10 1980-08-13 Anvar Immunising and anti-infectious adjuvant agents comprising peptide derivatives of muramic acid
FR2343482A1 (fr) * 1976-03-10 1977-10-07 Anvar La 2- (2-acetamido-2-deoxy-3-o-d-glucopyranosyl) -d-propionyl-l-seryl-d-isoglutamine et medicaments la contenant

Also Published As

Publication number Publication date
NO151088C (no) 1985-02-06
NO151201B (no) 1984-11-19
FI66878B (fi) 1984-08-31
HU182011B (en) 1983-12-28
PT69281A (de) 1979-03-01
IL56724A0 (en) 1979-05-31
ATA142079A (de) 1981-04-15
NO151201C (no) 1985-02-27
PL213696A1 (da) 1980-07-14
FI66878C (fi) 1984-12-10
NO790626L (no) 1979-08-27
AU4454679A (en) 1979-08-30
NO151088B (no) 1984-10-29
FI790584A (fi) 1979-08-25
JPS54141718A (en) 1979-11-05
JPH0130809B2 (da) 1989-06-22
CA1138436A (en) 1982-12-28
EP0003833A2 (de) 1979-09-05
EP0003833A3 (en) 1980-02-06
GB2015534A (en) 1979-09-12
IL56724A (en) 1982-12-31
ZA79893B (en) 1980-03-26
ES477977A1 (es) 1980-01-16
AR223833A1 (es) 1981-09-30
PL123315B1 (en) 1982-10-30
AT364718B (de) 1981-11-10
SU1055312A3 (ru) 1983-11-15
NO793993L (no) 1979-08-27
EP0003833B2 (de) 1990-12-19
DK79779A (da) 1979-08-25
DD141616A5 (de) 1980-05-14
ES483558A1 (es) 1980-04-16
DK161026B (da) 1991-05-21
NZ189756A (en) 1982-05-31
GR77615B (da) 1984-09-25
AU527549B2 (en) 1983-03-10
EP0003833B1 (de) 1983-07-20

Similar Documents

Publication Publication Date Title
DK158225C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK46079A (da) Fremgangsmaade til fremstilling af alkylendiaminderivater
DK158788C (da) Analogifremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater
DK156779A (da) Fremgangsmaade til fremstilling af cycloalkyltriazoler
DK129879A (da) Fremgangsmaade til fremstilling af n-heterocyclyl-4-piperidinaminer
DK266479A (da) Fremgangsmaade til fremstilling af 3-aminopropoxyarylderivater
DK303079A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK155669C (da) Analogifremgangsmaade til fremstilling af pleuromutilinderivater
DK146962C (da) Analogifremgangsmaade til fremstilling af indolizinderivater
DK161026C (da) Analogifremgangsmaade til fremstilling af antigenderivater
DK158984C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK186179A (da) Fremgangsmaade til fremstilling af carbapenemderivater
DK156643C (da) Analogifremgangsmaade til fremstilling af naphthalensulfonamidderivater
DK415379A (da) Fremgangsmaade til fremstilling af chromanolderivater
DK154434C (da) Analogifremgangsmaade til fremstilling af tripeptidderivater
DK150471C (da) Fremgangsmaade til fremstilling af trifluormethylphenoler
DK149748C (da) Analogifremgangsmaade til fremstilling af n-phenethylacetamidforbindelser
DK160281C (da) Fremgangsmaade til fremstilling af steroid-s-thioesterderivater
DK145179A (da) Fremgangsmaade til fremstilling af 4-methyl-5-hydroxymethyl-imidazol
DK157017C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK165325C (da) Analogifremgangsmaade til fremstilling af 4-aza-17-substituerede 5alfa-androstan-3-oner
DK348179A (da) Fremgangsmaade til fremstilling af carbazolyderivater
DK428079A (da) Fremgangsmaade til fremstilling af cyclohexadienderivater
DK185179A (da) Fremgangsmaade til fremstilling af 3-halogen-2-hydroxyalkyltrialkylammoniumunchlorider
DK239279A (da) Fremgangsmaade til fremstilling af 2-oximinophenylacetonitril

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
PBP Patent lapsed